Logo image
Prof. Dr. med. Andreas Stahl working place, University Hospital Greifswald
Prof. Dr. med. Andreas Stahl
Excellent
AiroScore
9.90

Prof. Dr. med. Andreas Stahl

ophthalmology
ophthalmology
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
98%19 years9.9/10$$$1181No

Overview

Country, City
Germany, Greifswald
Health facility
University Hospital Greifswald
Medical unit
Department of ophtalmology

About the doctor

Prof. Dr. med. Andreas Stahl is an esteemed ophthalmologist with 18 years of experience. He is currently the Director and Chair of the Department of Ophthalmology at the University Hospital Greifswald in Germany. Dr. Stahl has an impressive CV, including studying human medicine at the University of Freiburg and completing his doctoral thesis there. He also worked at renowned institutions such as Harvard Medical School in Boston, where he received a research scholarship. Dr. Stahl is specialized in ophthalmology and has obtained specialization from the European Board of Ophthalmology. Throughout his career, Dr. Stahl has contributed significantly to the field of ophthalmology. He has published an impressive number of scientific papers (1179) and has received numerous awards and grants for his innovative research in ophthalmology. Dr. Stahl's expertise lies in retinology, and he has led various clinical trials and studies in this area. He is also involved in the management of the Retina. net register, a multi-center database for the documentation of treatment patterns and courses of retinopathy of prematurity. Dr. Stahl's extensive experience, specialization, and contribution to the field make him a highly skilled and respected ophthalmologist. His research and clinical work in retinology demonstrates his dedication to improving the understanding and treatment of retinal diseases. Patients seeking top-quality ophthalmic care can trust Dr. Stahl's expertise and experience at the Department of Ophthalmology, University Hospital Greifswald.

Skills & Expertise

retinopathy
eye
children
ophthalmology
vegf
angiogenesis
ranibizumab
occlusion
retinal vein
vein
vein occlusion
bevacizumab
ribonucleic acids
neovascularization
carcinoma
retina
diabetic retinopathy
chorioretinopathy
retinal neovascularization
macular degeneration
nerve cells
agerelated macular degeneration
vitreoretinopathy
antivegf therapy
proliferative vitreoretinopathy
laser therapy
keratinocyte migration
panretinal laser
vascular occlusion
intravitreal injection
panretinal laser photocoagulation
hypotrophy
hypertrophy
brolucizumab
macular edema
canakinumab
vision
corneal lenses
retinal angiogenesis
unilateral maculopathy
ischemic neurons
vitrectomy
microangiopathy
macula
maculopathy
optical coherence tomography
macular surgery
choroidal neovascularisation
thrombotic microangiopathy
laserinduced choroidal neovascularisation

Resume

CV (Curriculum Vitae)

Education
  • 1998-2005 Studied human medicine at the University of Freiburg
  • 2001-2002 Scholarship for students at Imperial College of London from the German Academic Exchange Service
  • 2002-2005 Doctoral thesis at the University of Freiburg
  • 2004 Doctoral scholarship and Carl Duisberg grant for a research semester at Harvard Medical School of Boston from the German Academic Exchange Service
  • 2005 Approbation as a doctor in Germany and promotion to Dr. medical
  • 2006 Licensed to practice medicine in the USA
  • 2012 Obtaining specialization in ophthalmology from the European Board of Ophthalmology
  • 2013 Habilitation and a teaching license in ophthalmology
  • 2017 Qualification program for senior physicians at the Management Academy Baden-Wuerttemberg
Experience
  • 2004-2005 Practical year in Freiburg and Basel
  • 2006-2012 Assistant Doctor at the University Eye Clinic Freiburg
  • 2007 Teaching evaluation at the Virtual University of Bavaria
  • 2012-2013 Senior Physician at the University Eye Clinic Freiburg
  • 2013-2018 Senior Physician for retinology at the University Eye Clinic Freiburg
  • 2014-2018 Head of outpatient retinal operations at the University Eye Clinic Freiburg
  • 2015-2018 Managing Senior Physician at the University Eye Clinic Freiburg
  • 2017 Associate Professor of the University of Freiburg
  • 2019 Director and Chair of the Department of ophthalmology at the University Hospital Greifswald
  • 2019 University Professor at the University of Greifswald
Awards & Memberships
  • 2005 Research Award of the Human Tissue and Cell Research Foundation
  • 2005 Ludwig-Heilmeyer Doctoral Award from the University of Freiburg
  • 2006 Member of the German Ophthalmological Society
  • 2007 Member of the Association for Research in Vision and Ophthalmology
  • 2007 Research grant from the University of Freiburg
  • 2007 Advancement Award for innovative teaching from the dean of studies in Freiburg
  • 2008-2010 Research grant from the German Research Foundation for a stay at the Department of ophthalmology at the Harvard Medical School of Boston
  • 2009 Member of the Retinological Society
  • 2010 First place "Most Downloaded Articles" of the magazine “Investigative Ophthalmology & Visual Science”
  • 2010-2011 Returnee grant from the University of Freiburg
  • 2011 Research funding of the German Ophthalmologists Society for innovative projects in ophthalmology
  • 2011 Freifrau von Nauendorf Advancement Award in Wiesbaden
  • 2011 "EyeNovative" Sponsorship Award from Novartis Pharma
  • 2011 Formulation of the joint statement on anti-VEGF therapy in retinopathy of prematurity
  • 2011 Reviewer for the Velux Foundation of Denmark
  • 2011-2018 Head of the angiogenesis working group at the Freiburg Eye Clinic
  • 2012 Reviewer for the Icelandic Science Center 
  • 2012 "Best Poster" Award from the Macula Update
  • 2012 Member of the German Ophthalmological Society for the update of the guideline: "Ophthalmological screening examination of premature babies"
  • 2012-2015 MDK representative at the University Eye Clinic Freiburg
  • 2012-2021 Creation and management of the Retina.net register, a multi-center database for the documentation of treatment patterns and courses of retinopathy of prematurity
  • 2013 Reviewer for the German Research Society
  • 2013 Best Presentation from the French Ophthalmological Association in Paris
  • 2013 Consultant for the Austrian Fund for the Promotion of Scientific Research
  • 2014 Member of the steering committee of the RAINBOW study
  • 2014-2018 Research grant from the German Research Foundation: "Semaphorins as lead molecules of angiogenic retinal diseases"
  • 2014-2021 Member of the steering committee of the PRIDE study
  • 2014-2022 Design and Leader of the clinical trial of the CARE-ROP study, a multicenter, randomized, double-blind study on the efficacy of ranibizumab in retinopathy of prematurity
  • 2015 Reviewer for the British Research Council
  • 2015 Selection of the German Ophthalmological Society to participate in the European leadership development program
  • 2015 Retina Science Prize of the German Ophthalmic Surgeons
  • 2016 Member of the board of directors of the German Retinological Society
  • 2016 Reviewer for the Swiss National Science Foundation
  • 2017-2020 Federal Ministry of Education and Research of Germany joint funding: "Therapy prediction through analysis of patient data in ophthalmology"
  • 2017-2021 Member of the German Ophthalmological Society at the UV Protection Alliance of the Federal Office for Radiation Protection
  • 2019 Chairman of the Steering Committee of the FIREFLEYE study
  • 2019 Spokesman and Chairman of "retina.net", an association of research-based eye clinics to conduct clinical studies in Germany
  • 2020 Member of the teaching working group of the German Ophthalmological Association
  • 2021 Creation and Management of the EU-ROP register, an international database for the documentation of treatment patterns and courses of retinopathy of prematurity
  • 2022 Deputy Speaker of the digital health lab of the University Medicine Greifswald

Languages

English flag
English
German flag
German

Publications

Descemet's membrane endothelial keratoplasty is the predominant keratoplasty procedure in Germany since 2016: a report of the DOG-section cornea and its keratoplasty registry.

21 May, 2024

Hemodialysis and its impact on patient characteristics, microbiology, cardiac surgery, and mortality in infective endocarditis.

October, 2023

Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity.

October, 2023

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. med. Andreas Stahl?

The primary specialization of the doctor is ophthalmology.

What is the experience of the specialist?

Prof. Dr. med. Andreas Stahl has been practicing for more than 19 years.

What is the rating of the doctor?

What topics does Prof. Dr. med. Andreas Stahl expert at?

The doctor has excellent knowledge in retinopathy, eye, children, ophthalmology, vegf.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Andreas Stahl doesn’t perform virtual appointments.

Prof. Dr. med. Andreas Stahl
Prof. Dr. med. Andreas Stahl

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Andreas Stahl

Similar Doctors

Excellent
AiroScore
9.90
University Hospital Munster
ophthalmology, laser ophtalmological surgery
Excellent
AiroScore
9.90
Stuttgart Hospital
ophthalmology, cataract, uveitis, vitreous & retinal surgery, retinopathy, macular diseases
Excellent
AiroScore
9.90
Stuttgart Hospital
ophthalmology, glaucoma, retinal & refractive surgery, uveitis
Excellent
AiroScore
9.90
Stuttgart Hospital
ophthalmology, macular degeneration, vitreous & retinal surgery
Excellent
AiroScore
9.90